Which stock wins in a matchup between these two big drugmakers?
News & Analysis: Eli Lilly and Company
These three diabetes stocks should be on your radar right now.
LLY earnings call for the period ending March 31, 2019.
The big drugmaker missed Wall Street revenue expectations in Q1 but narrowly beat earnings estimates. Here's what you need to know.
Eli Lilly and GlaxoSmithKline are both pharma royalty. Which stock is the better buy right now?
AbbVie and Eli Lilly are two rock-solid dividend plays, but only one is a buy right now.
Pharmaceutical companies are suddenly eager to lower drug prices.
Find out which iconic pharmaceutical giant is the better stock pick at the moment.
See how the streamlined pharmaceutical company stacks up to the healthcare conglomerate.
One of these is paying a more generous dividend, but is it right for your portfolio?